April 24, 2026
According to Payal Rabde, who specializes in oncology biosimilars, inflammatory disease management, targeted biologic therapies, and biosimilar versions of monoclonal antibody therapies, with 4+ years of experience in market research and industry ana...
April 17, 2026
Biosimilar Contract Manufacturing Market (By Source: Mammalian, Non-mammalian; By Services: Recombinant Non-glycosylated Proteins, Recombinant Glycosylated Proteins; By Therapeutic Area: Oncology, Blood Disorders, Growth Hormonal Deficiency, Chronic ...
April 30, 2026
Biosimilar Antibodies Market (By Molecular Type: Monoclonal Antibodies (mAbs), Fusion Proteins; By Application: Oncology, Autoimmune Diseases, Others; By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies; By Region: Nort...
July 06, 2026
According to Rohan Patil, who specializes in biopharmaceuticals, biosimilars, and healthcare market intelligence, with 5+ years of experience in market research and industry analysis, the biosimilars market is set for strong long-term expansion, grow...
April 21, 2026
Projections indicate that, the global aflibercept biosimilars market will increase from USD 1.54 billion in 2024 to USD 3.7 billion by 2034, experiencing a CAGR of 9.14% over the next 10 years. The maturing ophthalmic biosimilar ecosystem is estimate...
August 10, 2026
According to Payal Rabde, who specializes in the development, manufacturing, and commercialization of biologic medicines, with 5+ years of experience in market research and industry analysis, extensive research indicates strong growth opportunities...
April 21, 2026
According to market estimations the global generic sterile injectable market was estimated at US$ 51.23 billion in 2025 and is projected to grow to US$ 82.14 billion by 2030. In 2023, North America led the market with a 40% share. Monoclonal antibodi...